ImmunoGen Message Board - Msg: 31260081

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Area51 who wrote (5580)	9/12/2017 3:12:36 PM
From: Gary Mohilner	Read Replies (1) of 5665

While I'd like to build up interest here, I doubt it will happen. I believe that news toward the end of the year mostly on IMGN853 will bring double digits, but even though the company said more shares were being issued, the formal filing today weakened the stock. In reality, IMGN over the decades has had the authority to issue far more shares than it has. When you compare it with SGEN regarding dilution, clearly SGEN has been far more open to it, and perhaps has grown because of having greater financial strength. It's still my belief that if IMGN's next successful drug comes before SGEN's next approved drug, IMGN's market cap will exceed that of SGEN. I'm speaking about 2020 very probably, but barring some positive moves from SGEN, I believe that IMGN will close in on them over the next few years. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next